GLP-1 prescribers should be aware of potential DED complications and how to ensure patients can experience the benefits of these drugs without compromising their ocular health
After an FDA roundtable raised alarms about antidepressant use in pregnancy, physicians warn the rhetoric could fuel fear, stigma, and dangerous gaps in care.